Urgada, Jocelyn C.

HRN: 28-68-26  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2026
CEFTAZIDIME 1GM (VIAL)
03/08/2026
03/14/2026
2GM
Iv
Q8
Cap Mr; Complicated UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines